Coloplast AS (OTCPK:CLPBF)
$ 128.575 7.425 (6.13%) Market Cap: 28.46 Bil Enterprise Value: 31.84 Bil PE Ratio: 39.13 PB Ratio: 11.87 GF Score: 94/100

Q1 2020 Coloplast A/S Earnings Call Transcript

Feb 06, 2020 / 02:00PM GMT
Release Date Price: $130
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the interim financial statements for Q1 2019 to 2020. (Operator Instructions) I must advise you all that the call is being recorded today, Thursday, the 6th of February 2020. And I shall now hand over to your speaker for today, Kristian Villumsen, CEO of Coloplast.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you, operator. Good afternoon, and welcome to our Q1 '19-'20 conference call. I'm Kristian Villumsen, CEO of Coloplast; and I'm joined by our CFO, Anders Lonning-Skovgaard; and our Investor Relations team.

We work with a short presentation by Anders and myself, like we usually do and then open up for questions.

Please turn to Slide #3. Coloplast started the year with another strong quarter, delivering 8% organic growth, a 13% increase in EBIT and a return on invested capital of 47%.

A few highlights from the first quarter include a solid start to the year in emerging markets driven by Ostomy Care and a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot